Ozempic was the only drug available for the full time period studied and had the highest prescriptions overall
Half a plate, not a full plate
People with treatment-resistant hypertension, especially those with co-existing diabetes, obesity, heart failure (HF), or chronic kidney disease (CKD) may particularly benefit from SGLT2-i and GLP-1RA
The material news: the March 9, 2026 Hims & Hers-Novo Nordisk partnership gives Hers patients legitimately branded oral Wegovy at $149/mo (intro through August 31, 2026, rising to $199 after)
That's a reason to keep on top of your nutrition and strength-training while on these drugs, he writes, "especially for older people like me, who are [already] susceptible to muscle loss." There are people who should steer clear of GLP-1 drugs, Kessler notes, including those with a personal or familial history of certain thyroid and endocrine cancers, those with chronic kidney disease, pancreatitis, inflammatory bowel diseases, uncontrolled diarrhea or constipation or gastroparesis, or if you are pregnant
Physical activity